Invention Grant
- Patent Title: Therapeutic use of specific ligand in MSRV associated diseases
-
Application No.: US15794541Application Date: 2017-10-26
-
Publication No.: US10059758B2Publication Date: 2018-08-28
- Inventor: Corinne Bernard , Alois Bernhardt Lang , Herve Perron , Jean-Baptiste Bertrand
- Applicant: GENEURO SA
- Applicant Address: CH Plan-les-Ouates
- Assignee: GENEURO SA
- Current Assignee: GENEURO SA
- Current Assignee Address: CH Plan-les-Ouates
- Agency: Oliff PLC
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/10 ; A61K39/00

Abstract:
A ligand includes each of the complementary-determining regions (CDRs) set forth in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 SEQ ID No. 4, SEQ ID No. 5 and SEQ ID No. 6 or any sequence having either number of substituted aminoacids within said sequences as indicated in the following, from 0 to 3 in CDR1 (SEQ ID No.1), from 0 to 2 in CDR2 (SEQ ID No.2), from 0 to 2 in CDR3 (SEQ ID No.3), from 0 to 1 in CDR4 (SEQ ID No.4), from 0 to 4 in CDR5 (SEQ ID No.5), from 0 to 2 in CDR6 (SEQ ID No.6), or aminoacids substituted with other aminoacids having equivalent chemical functions and properties, within said sequences SEQ ID No. 1 to SEQ ID No. 6.
Public/Granted literature
- US20180057569A1 THERAPEUTIC USE OF SPECIFIC LIGAND IN MSRV ASSOCIATED DISEASES Public/Granted day:2018-03-01
Information query